{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:43:01Z","timestamp":1779201781301,"version":"3.51.4"},"reference-count":115,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.survophthal.2021.03.007","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T21:33:13Z","timestamp":1617226393000},"page":"960-976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Corneal lymphangiogenesis as a potential target in dry eye disease - a systematic review"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8709-7807","authenticated-orcid":false,"given":"Mohansrinivas","family":"Chennakesavalu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3610-4613","authenticated-orcid":false,"given":"Sri Raghurama R.","family":"Somala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2748-248X","authenticated-orcid":false,"given":"Sunil R.","family":"Dommaraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8766-5456","authenticated-orcid":false,"given":"Meghna Priyanka","family":"Peesapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark I.","family":"Rosenblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Hong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitri T.","family":"Azar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2021.03.007_bib0001","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijo.IJO_646_17","article-title":"Anatomy of cornea and ocular surface","volume":"66","author":"Sridhar","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0002","doi-asserted-by":"crossref","first-page":"108090","DOI":"10.1016\/j.exer.2020.108090","article-title":"Descemet's membrane development, structure, function and regeneration","volume":"197","author":"de Oliveira","year":"2020","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0003","first-page":"S1","article-title":"Ocular surface disorders","volume":"30","author":"Khanna","year":"2017","journal-title":"Community Eye Health"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0004","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","article-title":"TFOS DEWS II report executive summary.","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0005","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jtos.2014.01.006","article-title":"The precorneal tear film as a fluid shell: the effect of blinking and saccades on tear film distribution and dynamics","volume":"12","author":"Yokoi","year":"2014","journal-title":"Ocul Surf"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2013.10.008","article-title":"Complexity of the tear film: importance in homeostasis and dysfunction during disease","volume":"117","author":"Dartt","year":"2013","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0007","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.sjopt.2014.06.002","article-title":"Dry eye disease: a review of diagnostic approaches and treatments","volume":"28","author":"Lin","year":"2014","journal-title":"Saudi J Ophthalmol"},{"issue":"quiz 82","key":"10.1016\/j.survophthal.2021.03.007_bib0008","first-page":"71","article-title":"The pathophysiology, diagnosis, and treatment of dry eye disease","volume":"112","author":"Messmer","year":"2015","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0009","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ajo.2019.01.026","article-title":"Estimated prevalence and incidence of dry eye disease based on coding analysis of a large, all-age United States health care system","volume":"202","author":"Dana","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0010","first-page":"192","article-title":"Dry eye syndrome","volume":"6","author":"Javadi","year":"2011","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0011","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: report of the definition and classification subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0012","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","article-title":"The pathophysiology of dry eye disease: what we know and future directions for research","volume":"124","author":"Pflugfelder","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0013","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1167\/iovs.08-2417","article-title":"Characterization of effector T cells in dry eye disease","volume":"50","author":"El Annan","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0014","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.4049\/jimmunol.182.3.1247","article-title":"Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression","volume":"182","author":"Chauhan","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0015","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9899.1000256","article-title":"Corneal lymphatics: role in ocular inflammation as inducer and responder of adaptive immunity","volume":"5","author":"Chauhan","year":"2014","journal-title":"J Clin Cell Immunol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0016","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature05249","article-title":"Corneal avascularity is due to soluble VEGF receptor-1","volume":"443","author":"Ambati","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0017","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/ICL.0000000000000042","article-title":"The core mechanism of dry eye disease is inflammation","volume":"40","author":"Wei","year":"2014","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0018","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/jop.2019.0060","article-title":"The immunological basis of dry eye disease and current topical treatment options","volume":"36","author":"Periman","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.survophthal.2021.03.007_bib0019","doi-asserted-by":"crossref","first-page":"e98222","DOI":"10.1172\/jci.insight.98222","article-title":"Goblet cell loss abrogates ocular surface immune tolerance","volume":"3","author":"Ko","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120284","article-title":"Immunomodulatory cross-talk between conjunctival goblet cells and dendritic cells","volume":"10","author":"Contreras-Ruiz","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.survophthal.2021.03.007_bib0021","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3390\/ijms18050978","article-title":"Goblet cells contribute to ocular surface immune tolerance-implications for dry eye disease","volume":"18","author":"Barbosa","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0022","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0300985812469883","article-title":"Getting leukocytes to the site of inflammation","volume":"50","author":"Muller","year":"2013","journal-title":"Vet Pathol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0023","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jtos.2013.10.007","article-title":"The chemokine receptor CCR7 expressed by dendritic cells: a key player in corneal and ocular surface inflammation","volume":"12","author":"Saban","year":"2014","journal-title":"Ocul Surf"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0024","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1167\/iovs.07-0069","article-title":"Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma","volume":"48","author":"De Paiva","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/mi.2009.5","article-title":"IL-17 disrupts corneal barrier following desiccating stress","volume":"2","author":"De Paiva","year":"2009","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0026","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.4049\/jimmunol.176.7.3950","article-title":"Desiccating stress induces T cell-mediated Sj\u00f6gren's Syndrome-like lacrimal keratoconjunctivitis","volume":"176","author":"Niederkorn","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0027","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7542929","article-title":"Review: the lacrimal gland and its role in dry eye","volume":"2016","author":"Conrady","year":"2016","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0028","first-page":"S177","article-title":"Ocular graft vs. host disease","volume":"3","author":"Kim","year":"2005","journal-title":"Ocul Surf"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0029","first-page":"264","article-title":"Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)","volume":"104","author":"Azar","year":"2006","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0030","doi-asserted-by":"crossref","first-page":"12331","DOI":"10.1038\/s41598-019-48811-z","article-title":"Application of corneal injury models in dual fluorescent reporter transgenic mice to understand the roles of the cornea and limbus in angiogenic and lymphangiogenic privilege","volume":"9","author":"Gao","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0031","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.preteyeres.2010.01.002","article-title":"Novel aspects of corneal angiogenic and lymphangiogenic privilege","volume":"29","author":"Ellenberg","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0032","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10384-010-0801-5","article-title":"Wound healing fibroblasts modulate corneal angiogenic privilege: interplay of basic fibroblast growth factor and matrix metalloproteinases in corneal angiogenesis","volume":"54","author":"Chang","year":"2010","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0033","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5114\/aoms.2015.49217","article-title":"Platelet-derived growth factors induced lymphangiogenesis: evidence, unanswered questions and upcoming challenges","volume":"11","author":"Jitariu","year":"2015","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0034","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1167\/iovs.13-13779","article-title":"Role of angiopoietin-2 in corneal lymphangiogenesis","volume":"55","author":"Yuen","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0035","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1038\/sj.emboj.7600763","article-title":"Hepatocyte growth factor promotes lymphatic vessel formation and function","volume":"24","author":"Kajiya","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0036","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.1111\/jcmm.14633","article-title":"TGFBIp mediates lymphatic sprouting in corneal lymphangiogenesis","volume":"23","author":"Lin","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0037","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1167\/iovs.18-25920","article-title":"Hyaluronan derived from the limbus is a key regulator of corneal lymphangiogenesis","volume":"60","author":"Sun","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0038","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fbioe.2018.00007","article-title":"Biology of vascular endothelial growth factor C in the Morphogenesis of lymphatic vessels","volume":"6","author":"Rauniyar","year":"2018","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0039","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/dbio.1997.8639","article-title":"VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane","volume":"188","author":"Oh","year":"1997","journal-title":"Dev Biol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0040","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1073\/pnas.95.2.548","article-title":"Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)","volume":"95","author":"Achen","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0041","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bcmd.2006.12.003","article-title":"Vascular endothelial growth factor family of ligands and receptors: review","volume":"38","author":"Otrock","year":"2007","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0042","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1161\/ATVBAHA.114.304881","article-title":"Molecular controls of lymphatic VEGFR3 signaling","volume":"35","author":"Deng","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.survophthal.2021.03.007_bib0043","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3390\/jcm9020479","article-title":"Role of endogenous regulators of hem- and Lymphangiogenesis in corneal transplantation","volume":"9","author":"Clahsen","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0044","doi-asserted-by":"crossref","DOI":"10.3390\/biom8010001","article-title":"Emerging roles for VEGF-D in human disease","volume":"8","author":"Stacker","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0045","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1167\/iovs.06-0570","article-title":"Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis","volume":"48","author":"Bock","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0046","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","article-title":"VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment","volume":"113","author":"Cursiefen","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0047","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1172\/JCI23874","article-title":"Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages","volume":"115","author":"Maruyama","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0048","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.0506112103","article-title":"Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision","volume":"103","author":"Cursiefen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0049","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm.2018","article-title":"Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth","volume":"15","author":"Albuquerque","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0050","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1073\/pnas.0404272101","article-title":"Dose-dependent response of FGF-2 for lymphangiogenesis","volume":"101","author":"Chang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0051","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1091\/mbc.e05-04-0368","article-title":"Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis","volume":"17","author":"Shin","year":"2006","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0052","doi-asserted-by":"crossref","first-page":"15894","DOI":"10.1073\/pnas.1208324109","article-title":"Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis","volume":"109","author":"Cao","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0053","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9613923","article-title":"Notch signaling pathway is involved in bFGF-induced corneal Lymphangiogenesis and Hemangiogenesis","volume":"2019","author":"Xie","year":"2019","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0054","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.febslet.2008.06.014","article-title":"Neostatin-7 regulates bFGF-induced corneal lymphangiogenesis","volume":"582","author":"Kojima","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0055","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.ajpath.2010.12.027","article-title":"A novel function for programmed death ligand-1 regulation of angiogenesis","volume":"178","author":"Jin","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0056","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1167\/iovs.03-0882","article-title":"Suppression of corneal neovascularization by PEDF release from human amniotic membranes","volume":"45","author":"Shao","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0057","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10520290802451085","article-title":"Immunohistochemistry in the evaluation of neovascularization in tumor xenografts","volume":"83","author":"Wang","year":"2008","journal-title":"Biotech Histochem"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0058","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.1167\/iovs.14-15638","article-title":"Consensus statement on the immunohistochemical detection of ocular lymphatic vessels","volume":"55","author":"Schroedl","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0059","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/MCB.01503-06","article-title":"Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1","volume":"27","author":"Gale","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0060","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1167\/iovs.13-13711","article-title":"The effect of podoplanin inhibition on lymphangiogenesis under pathological conditions","volume":"55","author":"Maruyama","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0061","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/dvdy.10163","article-title":"Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate","volume":"225","author":"Hong","year":"2002","journal-title":"Dev Dyn"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0062","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/emboj\/21.7.1505","article-title":"An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype","volume":"21","author":"Wigle","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0063","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/archophthalmol.2010.124","article-title":"Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity?","volume":"128","author":"Goyal","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0064","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/ICO.0b013e31821c9b5a","article-title":"Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye","volume":"30","author":"Lee","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0065","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archophthalmol.2011.266","article-title":"Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease","volume":"130","author":"Goyal","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0066","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ajo.2012.01.034","article-title":"Efficacy of topical blockade of interleukin-1 in experimental dry eye disease","volume":"154","author":"Okanobo","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0067","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jtos.2018.03.008","article-title":"Corneal lymphangiogenesis facilitates ocular surface inflammation and cell trafficking in dry eye disease","volume":"16","author":"Ji","year":"2018","journal-title":"Ocul Surf"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0068","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/ICO.0000000000000107","article-title":"Dry eye predisposes to corneal neovascularization and lymphangiogenesis after corneal injury in a murine model","volume":"33","author":"Cho","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0069","first-page":"218","article-title":"Comparison of postoperative corneal changes between dry eye and non-dry eye in a murine cataract surgery model","volume":"9","author":"Kwon","year":"2016","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0070","doi-asserted-by":"crossref","first-page":"e1309","DOI":"10.1038\/cddis.2014.260","article-title":"Activation of HIF-1\u03b1 (hypoxia inducible factor-1\u03b1) prevents dry eye-induced acinar cell death in the lacrimal gland","volume":"5","author":"Seo","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0071","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147846","article-title":"Activation of Dll4\/Notch signaling and hypoxia-inducible factor-1 alpha facilitates Lymphangiogenesis in lacrimal glands in dry eye","volume":"11","author":"Min","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0072","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1182\/blood-2011-01-332049","article-title":"A novel pro-lymphangiogenic function for Th17\/IL-17","volume":"118","author":"Chauhan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0073","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jtos.2018.07.005","article-title":"The immunoregulatory role of corneal epithelium-derived thrombospondin-1 in dry eye disease","volume":"16","author":"Tan","year":"2018","journal-title":"Ocul Surf"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0074","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1084\/jem.20092277","article-title":"Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes","volume":"208","author":"Cursiefen","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0075","first-page":"1","article-title":"The Important Role of the Chemokine Axis CCR7-CCL19 and CCR7-CCL21 in the Pathophysiology of the Immuno-inflammatory Response in Dry Eye Disease","author":"Wang","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0076","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2147\/OPTH.S150957","article-title":"Topical ocular 0.1% cyclosporine A cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access program","volume":"12","author":"Pisella","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0077","doi-asserted-by":"crossref","first-page":"e16710","DOI":"10.1097\/MD.0000000000016710","article-title":"Efficacy and safety of 0.05% cyclosporine ophthalmic emulsion in treatment of Chinese patients with moderate to severe dry eye disease: A 12-week, multicenter, randomized, double-masked, placebo-controlled phase III clinical study","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0078","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/09273948.2017.1341988","article-title":"The use of topical corticosteroids for treatment of dry eye syndrome","volume":"27","author":"Cutolo","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0079","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12325-019-01137-8","article-title":"topical low dose preservative-free hydrocortisone reduces signs and symptoms in patients with chronic dry eye: a randomized clinical trial","volume":"37","author":"Kallab","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0080","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11095-018-2556-5","article-title":"Ocular pharmacokinetics of a topical ophthalmic nanomicellar solution of cyclosporine (Cequa\u00ae) for dry eye disease","volume":"36","author":"Mandal","year":"2019","journal-title":"Pharm Res"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0081","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/14740338.7.1.79","article-title":"Uses and safety profile of ciclosporin in ophthalmology","volume":"7","author":"Kashani","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0082","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jtos.2014.12.006","article-title":"Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-analysis","volume":"13","author":"Wan","year":"2015","journal-title":"Ocul Surf"},{"issue":"9","key":"10.1016\/j.survophthal.2021.03.007_bib0083","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3390\/jcm8091439","article-title":"Dry eye disease: emerging approaches to disease analysis and therapy","volume":"8","author":"Heidari","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0084","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3109\/09273948.2010.498657","article-title":"Clinical review: topical ophthalmic use of cyclosporin A","volume":"18","author":"Utine","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jtos.2016.01.001","article-title":"Lifitegrast, a novel integrin antagonist for treatment of dry eye disease","volume":"14","author":"Perez","year":"2016","journal-title":"Ocul Surf"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0086","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40265-016-0681-1","article-title":"Lifitegrast Ophthalmic Solution 5%: A review in dry eye disease","volume":"77","author":"Keating","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0087","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/ICO.0000000000000803","article-title":"Safety of Lifitegrast ophthalmic solution 5.0% in patients with dry eye disease: a 1-year, multicenter, randomized, placebo-controlled study","volume":"35","author":"Donnenfeld","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0088","article-title":"Dry eye management: targeting the ocular surface microenvironment","volume":"18","author":"Zhang","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0089","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bjp.0706736","article-title":"How corticosteroids control inflammation: quintiles prize lecture 2005","volume":"148","author":"Barnes","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0090","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.3760\/cma.j.issn.0366-6999.20140048","article-title":"Clinical efficacy of 0.1% pranoprofen in treatment of dry eye patients: a multicenter, randomized, controlled clinical trial","volume":"127","author":"Chen","year":"2014","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0091","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/APO.0000000000000032","article-title":"Efficacy of bromfenac sodium ophthalmic solution for treatment of dry eye disease","volume":"4","author":"Fujishima","year":"2015","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0092","first-page":"877","article-title":"Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE\u2122) model","volume":"9","author":"Sosne","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0093","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00002018-200225040-00002","article-title":"Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review","volume":"25","author":"Gaynes","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0094","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2019.07.001","article-title":"NSAID-induced corneal melt: clinical importance, pathogenesis, and risk mitigation","volume":"65","author":"Rigas","year":"2020","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0095","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1167\/iovs.05-1281","article-title":"Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline","volume":"47","author":"De Paiva","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0096","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.exer.2006.02.004","article-title":"Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye","volume":"83","author":"De Paiva","year":"2006","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0097","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jamaophthalmol.2015.2326","article-title":"Effects of azithromycin on gene expression profiles of proinflammatory and anti-inflammatory mediators in the eyelid margin and conjunctiva of patients with meibomian gland disease","volume":"133","author":"Zhang","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0098","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1084\/jem.20091385","article-title":"VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis","volume":"207","author":"Wuest","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0099","first-page":"3043","article-title":"Efficiency and safety of subconjunctival injection of anti-VEGF agent - bevacizumab - in treating dry eye","volume":"9","author":"Jiang","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234186","article-title":"Efficacy of topical bevacizumab 0.05% eye drops in dry eye disease: A double-masked, randomized trial","volume":"15","author":"Kasetsuwan","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0101","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00002018-200427090-00003","article-title":"Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids","volume":"27","author":"Allain","year":"2004","journal-title":"Drug Saf"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0102","doi-asserted-by":"crossref","first-page":"11714","DOI":"10.1074\/jbc.M109.064618","article-title":"Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitors","volume":"285","author":"Fern\u00e1ndez","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0103","first-page":"35","article-title":"Improvement in the signs and symptoms of dry eye disease with dobesilate eye drops","volume":"2","author":"Cuevas","year":"2015","journal-title":"Mil Med Res"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0104","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1158\/0008-5472.CAN-12-4539","article-title":"VEGF-C and VEGF-D blockade inhibits inflammatory skin carcinogenesis","volume":"73","author":"Alitalo","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0105","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1167\/iovs.11-8668","article-title":"Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis","volume":"53","author":"Hajrasouliha","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0106","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/med.21496","article-title":"Potential lymphangiogenesis therapies: learning from current antiangiogenesis therapies-A review","volume":"38","author":"Yamakawa","year":"2018","journal-title":"Med Res Rev"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0107","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1167\/iovs.12-10856","article-title":"Sunitinib inhibits inflammatory corneal lymphangiogenesis","volume":"54","author":"Detry","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0108","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1167\/iovs.16-20485","article-title":"Angiopoietin-2 blockade promotes survival of corneal transplants","volume":"58","author":"Zhang","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0109","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/jcmm.12164","article-title":"Mac Gabhann F: a systems biology view of blood vessel growth and remodelling","volume":"18","author":"Logsdon","year":"2014","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","article-title":"Dry eye disease: an immune-mediated ocular surface disorder","volume":"130","author":"Stevenson","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0111","first-page":"1541","article-title":"Effect of trapping vascular endothelial growth factor-a in a murine model of dry eye with inflammatory neovascularization","volume":"9","author":"Kwon","year":"2016","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0112","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2147\/OPTH.S5555","article-title":"Etiology, prevalence, and treatment of dry eye disease","volume":"3","author":"Gayton","year":"2009","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0113","series-title":"Dry Eye: A Practical Approach","first-page":"1","article-title":"The definition and classification of dry eye disease","author":"Bron","year":"2015"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0114","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cell.2010.01.045","article-title":"Lymphangiogenesis: Molecular mechanisms and future promise","volume":"140","author":"Tammela","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.survophthal.2021.03.007_bib0115","doi-asserted-by":"crossref","DOI":"10.3390\/cells8030270","article-title":"Two birds, one stone: double hits on tumor growth and Lymphangiogenesis by targeting vascular endothelial growth factor receptor 3","volume":"8","author":"Hsu","year":"2019","journal-title":"Cells"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625721000801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625721000801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T18:07:07Z","timestamp":1758737227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625721000801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":115,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0039625721000801"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2021.03.007","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corneal lymphangiogenesis as a potential target in dry eye disease - a systematic review","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2021.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}